Study of high-dose Pitavastatin on lipid and glucose metabolism disorder in Coronary Artery Disease. (Shield-CAD)
Latest Information Update: 18 May 2016
At a glance
- Drugs Pitavastatin (Primary)
- Indications Hypercholesterolaemia
- Focus Pharmacodynamics
- Acronyms Shield-CAD
- 14 Aug 2012 New trial record
- 10 Aug 2012 Planned End Date changed from 30 Sep 2014 to 31 Oct 2014 as reported by University Hospital Medical Information Network - Japan record (UMIN000008671).